Amyloid beta–positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity-Reference-Cited by-同舟云学术

Amyloid beta–positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity

Published:2019-02 Issue: Volume:74 Page:191-201
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Avants Brian B.,Hutchison R. Matthew,Mikulskis Alvydas,Salinas-Valenzuela Cristian,Hargreaves Richard,Beaver John,Chiao Ping

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference114 articles.

1. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects;Araque Caballero;Neurobiol. Aging,2015

2. The pediatric template of brain perfusion;Avants;Sci. Data,2015

3. Relating high-dimensional structural networks to resting functional connectivity with sparse canonical correlation analysis for neuroimaging;Avants,2018

4. Resting-state network dysfunction in Alzheimer's disease: a systematic review and meta-analysis;Badhwar;Alzheimers Dement. (Amst),2017

5. Clinical and biomarker changes in dominantly inherited Alzheimer's disease;Bateman;N. Engl. J. Med.,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological Effects of Repeated Blast Exposure in Special Operations Personnel;Journal of Neurotrauma;2024-01-12

2. The role of glucose in cognition, risk of dementia, and related biomarkers in individuals without type 2 diabetes mellitus or the metabolic syndrome: A systematic review of observational studies;Neuroscience & Biobehavioral Reviews;2022-04

3. A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non‐converter Alzheimer's disease subjects with consideration for their amyloid beta status;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2022-01

4. Electrochemical Immunosensor for the Sensitive Detection of Alzheimer's Biomarker Amyloid‐β (1–42) Using the Heme‐amyloid‐β (1–42) Complex as the Signal Source;Electroanalysis;2021-11-15

5. Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease;Alzheimer's & Dementia;2021-09-28